Search
Former OpenAI Science Lead Founds Warp Sciences, Raises $215 Million to Build Robotic Drug Labs
1 day ago /
Read about 0 minute
Author：小编
Kevin Weil, former Chief Product Officer and Head of the Science Team at OpenAI, has founded Warp Sciences with the goal of introducing artificial intelligence and robotics into drug development laboratories, helping biotech and pharmaceutical companies accelerate the manufacturing and testing of candidate compounds. Recently, Weil announced that the company has completed a $215 million funding round, led by Lightspeed, with the company's valuation reportedly reaching $865 million. Additionally, institutions such as IVP, Premji Invest, Mayfield, Lux Capital, and Menlo Ventures also participated in the investment.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
